Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

48 hours post-treatment L-Carnitine Pharmacometabolomics in Sepsis (CaPS) Patients

ABSTRACT:

ORGANISM(S): Homo Sapiens

TISSUE(S): Blood

DISEASE(S): Sepsis

PROVIDER: ST001354 | MetabolomicsWorkbench |

REPOSITORIES: MetabolomicsWorkbench

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	mwtab	Other

Items per page:

1 - 1 of 1

Similar Datasets

Pre-treatment L-Carnitine Pharmacometabolomics in Sepsis (CaPS) Patients

Project description: Not available

| ST001319 | MetabolomicsWorkbench

Pharmacometabolomics of L-Carnitine Treatment Response Phenotypes in Patients with Septic Shock

Project description: Not available

| ST000785 | MetabolomicsWorkbench

Huh7 cells proteoic analysis withtomatidine treatment at 6 and 16 hours post-treatment

Project description:Tomatidine, a natural steroidal alkaloid from unripe green tomatoes has been shown to exhibit many health benefits. We recently provided in vitro evidence that tomatidine reduces the infectivity of Dengue virus (DENV) and Chikungunya virus (CHIKV), two medically important arthropod-borne human infections for which no treatment options are available. The objective of this mass spectrometry analysis was to determine possible proteomic changes in the human cell line Huh7 induced by tomatidine which may be indicative of the underlying antiviral activity of tomatidine.

2021-11-18 | PXD028693 | Pride

Characterizing acyl-carnitine biosignatures for schizophrenia: a longitudinal pre- and post-treatment study.

Project description: Not available

| S-EPMC6336814 | biostudies-literature

Post-discharge functional outcomes in older patients with sepsis.

Project description: Not available

| S-EPMC11363546 | biostudies-literature

Pharmacometabolomics of l-carnitine treatment response phenotypes in patients with septic shock.

Project description: Not available

| S-EPMC4342803 | biostudies-literature

The Universal Vital Assessment (UVA) score at 6 hours post-resuscitation predicts mortality in hospitalized adults with severe sepsis in Mbarara, Uganda.

Project description: Not available

| S-EPMC11495629 | biostudies-literature

Transcriptome analysis of six tissues obtained post mortem from sepsis patients

Project description:Background: Septic shock is a life-threatening clinical condition characterized by a robust immune inflammatory response to disseminated infection. Little is known about its impact on the transcriptome of distinct human organs. Objective and Methods: To address this, we performed RNA sequencing of samples from the prefrontal cortex, hippocampus, heart, lung, kidney and colon of seven individuals who succumbed to sepsis and seven uninfected controls. Main Results: We identified that the lungs and colon were the most affected organs. While gene activation dominated, strong inhibitory signals were also detected, particularly in the lungs. Principal Conclusions: We found that septic shock is an extremely heterogeneous disease, not only when different individuals are investigated, but also when comparing different tissues of the same patient. However, several pathways, such as respiratory electron transport and other metabolic functions, revealed distinctive alterations, providing evidence that tissue specificity is a hallmark of sepsis. Strikingly, we found evident signals of accelerated ageing in our sepsis population.

2023-09-21 | GSE237861 | GEO

Short turnaround time of seven to nine hours from sample collection until informed decision for sepsis treatment using nanopore sequencing.

Project description: Not available

| S-EPMC10951244 | biostudies-literature

chronic carnitine treatment (negative mode)

Project description:Samples from mice infected and then treated with vehicle, carnitine or benznidazole in the chronic stage of infection. Tissue samples extracted with 50% methanol followed by 3:1 dichloromethane:methanol. C8 chromatography with negative mode data acquisition

2023-11-13 | MSV000093394 | MassIVE

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data